First Choice Healthcare Solutions, Inc. (FCHS): Total Liabilities
$43.58M
As of 2025-12-31
$10.08M
As of 2026-06-30
+17.4%
3-year compound annual growth
+8.3%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $43.58M | +17.8% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $36.98M | +16.8% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $31.65M | +17.6% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $26.92M | n/a | 2024-05-13, Balance as of period end |
| No annual figure between 2017-12-31 and 2022-12-31. | |||
| 2017-12-31 | $7.27M | +1.1% | 2018-04-03, Balance as of period end |
| 2016-12-31 | $7.19M | -63.3% | 2018-04-03, Balance as of period end |
| 2015-12-31 | $19.59M | +33.8% | 2017-04-03, Balance as of period end |
| 2014-12-31 | $14.63M | +7.6% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $13.60M | +19.0% | 2015-04-15, Balance as of period end |
| 2012-12-31 | $11.43M | +46.6% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $7.80M | +33.3% | 2013-04-01, Balance as of period end |
| 2010-12-31 | $5.85M | n/a | 2012-03-30, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $43.58M | +17.8% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $837.3K | -27.4% |
| Advanced Biomed Inc. (ADVB) | 2026-06-30 | $1.47M | -92.4% |
| YD Bio Ltd (YDES) | 2025-12-31 | $16.64M | n/m |
| CapForce Inc. (CFOR) | 2025-12-31 | $6.20M | +149.7% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Ludwig Enterprises, Inc. (LUDG) | 2025-12-31 | $4.64M | +80.0% |
Compare FCHS, BGLC, ACON, ADVB side by side · Screen every company in Services-Medical Laboratories ↗